Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung

被引:130
|
作者
Schobert, Max [1 ]
Jahn, Dieter [1 ]
机构
[1] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany
关键词
Pseudamonas aeruginosa; Anaerobic physiology; Antibiotic tolerance; Cystic fibrosis; Denitrification; Arginine fermentation; Pyruvate fermentation; NO-signaling; Universal stress protein; UNIVERSAL STRESS-PROTEIN; INSENSITIVE TERMINAL OXIDASE; AIRWAY SURFACE DEHYDRATION; GLOBAL ACTIVATOR GACA; SMALL-COLONY VARIANTS; NITRIC-OXIDE; NITRATE REDUCTASE; BIOFILM FORMATION; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATOR;
D O I
10.1016/j.ijmm.2010.08.007
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
During chronic infection of the cystic fibrosis (CF) lung, Pseudomonas aeruginosa grows and persists in a microaerobic to anaerobic environment. P. aeruginosa is well adapted to thrive under such conditions and contains multiple enzyme systems for energy generation under oxygen-restricted or even anaerobic conditions. Recent data confirm a heterogeneous environment in the CF lung and indicate that P. aeruginosa induces enzyme systems for microaerobic growth but also denitrification and fermentative pathways. Moreover, stress response systems as universal stress proteins enhance survival under anaerobic energy starvation conditions. Growth in these oxygen-limited environments induces a drastic physiological change in P. aeruginosa, like increased alginate production and alterations in the outer membrane, which contribute to an increased antibiotic tolerance. (C) 2010 Elsevier GmbH. All rights reserved.
引用
收藏
页码:549 / 556
页数:8
相关论文
共 50 条
  • [21] High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection
    Oliver, A
    Cantón, R
    Campo, P
    Baquero, F
    Blázquez, J
    [J]. SCIENCE, 2000, 288 (5469) : 1251 - 1253
  • [22] Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis
    Barclay, ML
    Begg, EJ
    Chambers, ST
    Thornley, PE
    Pattemore, PK
    Grimwood, K
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (06) : 1155 - 1164
  • [23] THE PATHOGENESIS OF PSEUDOMONAS-AERUGINOSA LUNG INFECTIONS IN CYSTIC-FIBROSIS
    GRIMWOOD, K
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1992, 28 (01) : 4 - 11
  • [24] CHRONIC LUNG INFECTION WITH PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS
    CHANEY, HR
    FINK, RJ
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 1991, 4 (02) : 140 - 144
  • [25] Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection
    Pukhalsky, AL
    Kapranov, NI
    Kalashnikova, EA
    Shmarina, GV
    Shabalova, LA
    Kokarovtseva, SN
    Pukhalskaya, DA
    Kashirskaja, NJ
    Simonova, OI
    [J]. MEDIATORS OF INFLAMMATION, 1999, 8 (03) : 159 - 167
  • [26] EARLY PSEUDOMONAS AERUGINOSA TREATMENT AND LUNG FUNCTION IN PEDIATRIC CYSTIC FIBROSIS
    Casaredi, Gascon, I
    Klingel, M.
    Waters, V. J.
    Ratjen, F.
    [J]. PEDIATRIC PULMONOLOGY, 2019, 54 : S428 - S428
  • [27] Pathogenicity of obligate anaerobes in the cystic fibrosis lung: interaction with Pseudomonas aeruginosa
    Worlitzsch, D.
    Jaschinski, A.
    Stotz, M.
    Liemen, A.
    Bensel, T.
    Wollschlaeger, B.
    Borneff-Lipp, M.
    [J]. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 299 : 73 - 74
  • [28] Phenotypes That Matter: Pseudomonas aeruginosa and Progression of Cystic Fibrosis Lung Disease
    Sanders, Don B.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 190 (03) : 245 - 246
  • [29] PSEUDOMONAS AERUGINOSA METALLOPROTEASES INHIBITION REDUCES LUNG DAMAGE IN CYSTIC FIBROSIS
    Bergamini, G.
    Stellari, F.
    Sandri, A.
    Thibodeau, P. H.
    Assael, B. M.
    Villetti, G.
    Melotti, P.
    Sorio, C.
    [J]. PEDIATRIC PULMONOLOGY, 2016, 51 : 231 - 231
  • [30] Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis lung infections
    Behrends, V.
    Ryall, B.
    Zlosnik, J. E. A.
    Speert, D. A.
    Williams, H. D.
    Bundy, J. G.
    [J]. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 302 : 109 - 109